Immune responses to infections occur in two phases, an early relatively nonspecitic (innate) response and a later specific (adaptive or acquired).response associated with the expansions of antigen-reactive clones of T and B cells. My laboratory in the 1970s helped develop this paradigm by demonstrating an interferon (IFN)- induced activated natural killer (NK) cell peak followed by a virus-specific cytotoxic T cell peak. NK cells are now considered important anti-viral components of the innate immune system. Paradoxically, we now have surprising evidence that the depletion of NK cells can sometimes enhance viral clearance or inhibit immunopathological disease. Under these conditions NK cells are harmful to host because they alter the acquired immune response, in part by killing activated CD4 T cells, which regulate viral infections directly and indirectly by their actions on CDS T cells and B cells. However, under other conditions the presence of NK cells is needed to promote persistent infections, also in part due to their ability to regulate T cell responses. We show here that whereas the inhibitory molecule 2B4 restrains NK cells from attacking CDS T cells, activated NK cells can kill activated CD4 T cells and in so doing decrease both CD4 and CDS T cell numbers and functionality during viral infections. We propose to determine, using several different systems, the mechanism(s) by which NK cells affect newly developing T cell responses and contribute to the pathogenesis of viral disease in the lung, and we will collaborate with, other program investigators to translate these findings into human systems. Specifically, we propose the following specific aims:
Specific Aim #1 : To determine whether the direct NK cell control of T cell responses is a universal feature in anti-viral T cell responses.
Specific Aim #2 : To determine, in collaboration with Project 2 and Core 0, the functional, physiological, and antigenic state of 004 T cells that are susceptible to NK cell mediated lysis.
Specific Aim #3 : To determine the role of NK cells in regulating antiviral antibody responses.
Specific Aim #4 : To examine the NK cell-dependent regulation of pathology and persistence and effects of NK cells on T cell exhaustion. The work meets the objectives of RFA-AI-12-048, in that it (1) examines interactions between innate and adaptive immune mechanisms in viral systems, (2) examines such actions at mucosal sites, in this case the lung, and (3) examines how different T and B cell subsets are maintained after infection.

Public Health Relevance

The pathogenesis of many acute and persistent viral infections is controlled by T cells, but we show here that these T cell responses may be substantially regulated by NK cells activated at early stages of infection Clarifying this phenomenon will help in providing insights on how the immune system interacts with viruses to make one sick, and it may help to promote the development of more efficient viral vaccines and therapies for persistent infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI109858-05
Application #
9526788
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Mallia, Conrad M
Project Start
Project End
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
Strutt, T M; Dhume, K; Finn, C M et al. (2018) IL-15 supports the generation of protective lung-resident memory CD4 T cells. Mucosal Immunol 11:668-680
Devarajan, Priyadharshini; Jones, Michael C; Kugler-Umana, Olivia et al. (2018) Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus. Front Immunol 9:596
Hatfield, Steven D; Daniels, Keith A; O'Donnell, Carey L et al. (2018) Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity. Virology 519:131-144
Becerra-Artiles, Aniuska; Santoro, Tessa; Stern, Lawrence J (2018) Evaluation of a method to measure HHV-6B infection in vitro based on cell size. Virol J 15:4
Marshall, Nikki B; Vong, Allen M; Devarajan, Priyadharshini et al. (2017) NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol 198:1142-1155
Blevins, Sydney; Huseby, Eric S (2017) Killer T cells with a beta-flavi(r) for dengue. Nat Immunol 18:1186-1188
Antunes, Dinler A; Rigo, Maurício M; Freitas, Martiela V et al. (2017) Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy. Front Immunol 8:1210
Shin, Hyun Mu; Kapoor, Varun N; Kim, Gwanghun et al. (2017) Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog 13:e1006544
Song, InYoung; Gil, Anna; Mishra, Rabinarayan et al. (2017) Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope. Nat Struct Mol Biol 24:395-406
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210

Showing the most recent 10 out of 41 publications